Eligibility for opiate substitution therapy in recently released prisoners with high-risk amphetamine use, and their perceptions of its effectiveness

References

• American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR (Vol. 4th, text revision.). Washington, DC: American Psychiatric Association.
   Google Scholar
• Bahr, S. J., Masters, A. L., & Taylor, B. M. (2012). What works in substance abuse treatment programs for offenders? The Prison Journal, 92(2), 155–174. doi:10.1177/0032885512438836
   Web of Science ®Google Scholar
• Binswanger, I. A., Nowels, C., Corsi, K. F., Glanz, J., Long, J., Booth, R. E., & Steiner, J. F. (2012). Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors. Addiction Science & Clinical Practice, 7(1), 3–3. doi:10.1186/1940-0640-7-3
   PubMedGoogle Scholar
• Brecht, M.-L., & Herbeck, D. (2014). Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors. Drug and Alcohol Dependence, 139, 18–25. doi:10.1016/j.drugalcdep.2014.02.702
   PubMed Web of Science ®Google Scholar
• Brensilver, M., Heinzerling, K. G., & Shoptaw, S. (2013). Pharmacotherapy of amphetamine‐type stimulant dependence: An update. Drug and Alcohol Review, 32(5), 449–460. doi:10.1111/dar.12048
   PubMed Web of Science ®Google Scholar
• Chalmers, J., Bradford, D., & Jones, C. (2010). The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia. International Journal of Drug Policy, 21(5), 381–389. doi:10.1016/j.drugpo.2010.06.002
   PubMed Web of Science ®Google Scholar
• Ciketic, S., Hayatbakhsh, M. R., Doran, C. M., & Najman, J. M. (2011). A review of psychological and pharmacological treatment options for methamphetamine dependence. Journal of Substance Use, 17(4), 1–21. doi:10.3109/14659891.2011.592900
   Web of Science ®Google Scholar
• Darke, S. (2013). Pathways to heroin dependence: Time to re‐appraise self‐medication. Addiction (Abingdon, England), 108(4), 659–667. doi:10.1111/j.1360-0443.2012.04001.x
   PubMed Web of Science ®Google Scholar
• Fatovich, D. M., Davis, G., & Bartu, A. (2012). Morbidity associated with amphetamine‐related presentations to an emergency department: A record linkage study. Emergency Medicine Australasia, 24(5), 553–559. doi:10.1111/j.1742-6723.2012.01590.x
   PubMed Web of Science ®Google Scholar
• Fox, A. D., Maradiaga, J., Weiss, L., Sanchez, J., Starrels, J. L., & Cunningham, C. O. (2015). Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder. Addiction Science & Clinical Practice, 10(1), 2–2. doi:10.1186/s13722-014-0023-0
   PubMed Web of Science ®Google Scholar
• Gjersing, L., & Bretteville-Jensen, A. L. (2013). Is opioid substitution treatment beneficial if injecting behaviour continues? Drug and Alcohol Dependence, 133(1), 121. doi:10.1016/j.drugalcdep.2013.05.022
   PubMed Web of Science ®Google Scholar
• Heilbronn, C., Gao, C. X., Lloyd, B., Smith, K., Best, D., & Lubman, D. I. (2013). Trends in amphetamine-related harms in Victoria. The Medical Journal of Australia, 199(6), 395.
   PubMed Web of Science ®Google Scholar
• Horyniak, D., Stoové, M., Degenhardt, L., Aitken, C., Kerr, T., & Dietze, P. (2015). How do drug market changes affect characteristics of injecting initiation and subsequent patterns of drug use? Findings from a cohort of regular heroin and methamphetamine injectors in Melbourne, Australia. The International Journal on Drug Policy, 26(1), 43–50. doi:10.1016/j.drugpo.2014.09.002
   PubMed Web of Science ®Google Scholar
• Kaye, S., Darke, S., & Torok, M. (2013). Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: a hidden disorder? Addiction, 108(5), 923–931. doi:10.1111/add.12086
   PubMed Web of Science ®Google Scholar
• Kenny, P., Harney, A., Lee, N. K., & Pennay, A. (2011). Treatment utilization and barriers to treatment: Results of a survey of dependent methamphetamine users. Substance Abuse Treatment, Prevention, and Policy, 6(1), 1–7. doi:10.1186/1747-597x-6-3
   PubMed Web of Science ®Google Scholar
• Kiepek, N., & Magalhães, L. (2011). Addictions and Impulse-Control Disorders as Occupation: A Selected Literature Review and Synthesis. Journal of Occupational Science, 18(3), 254. doi:10.1080/14427591.2011.581628
   Google Scholar
• Kinner, S. A., Jenkinson, R., Gouillou, M., & Milloy, M. J. (2012). High-risk drug-use practices among a large sample of Australian prisoners. Drug and Alcohol Dependence, 126(1–2), 156–160. doi:10.1016/j.drugalcdep.2012.05.008
   PubMed Web of Science ®Google Scholar
• Lee, N. K., & Rawson, R. A. (2008). A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Reviews, 27(3), 309–317. doi:10.1080/09595230801919494
   PubMed Web of Science ®Google Scholar
• Lubman, D. I., Baker, A. L., McKetin, R., Dawe, S., & Ali, R. L. (2013). Dose-related psychotic symptoms in chronic methamphetamine users: Evidence from a prospective longitudinal study. JAMA Psychiatry, 70(3), 319–324. doi:10.1001/jamapsychiatry.2013.283
   PubMed Web of Science ®Google Scholar
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews, 2002, Issue 4.
   Google Scholar
• McKetin, R., Najman, J. M., Baker, A. L., Lubman, D. I., Dawe, S., Ali, R., … Mamun, A. (2012). Evaluating the impact of community‐based treatment options on methamphetamine use: Findings from the Methamphetamine Treatment Evaluation Study (MATES). Addiction, 107(11), 1998–2008. doi:10.1111/j.1360-0443.2012.03933.x
   PubMed Web of Science ®Google Scholar
• Pérez-Mañá, C., Castells, X., Torrens, M., Capellà, D., & Farre, M. (2013). Efficacy of psychostimulant drugs for amphetamine abuse or dependence. The Cochrane Database of Systematic Reviews, 2013, Issue 9.
   Google Scholar
• Queensland_Health. (2012). Queensland Opioid Treatment Program: Clinical Guidelines 2012. (ISBN: 978-1-921707-11-7). Brisbane, Queensland, Australia: Queensland Government. Retrieved from http://www.dovetail.org.au/media/54648/2012%20qotp%20clinical%20guidelines.pdf.
   Google Scholar
• Quinn, B., Stoové, M., Papanastasiou, C., & Dietze, P. (2013). An exploration of self-perceived non-problematic use as a barrier to professional support for methamphetamine users. The International Journal on Drug Policy, 24(6), 619. doi:10.1016/j.drugpo.2013.05.015
   PubMed Web of Science ®Google Scholar
• Richmond, R. L., Indig, D., Butler, T. G., Wilhelm, K. A., Archer, V. A., & Wodak, A. D. (2013). Smoking and other drug characteristics of aboriginal and non-aboriginal prisoners in Australia. Journal of Addiction, 2013, 1–9. doi:10.1155/2013/516342
   Google Scholar
• Roth, A. M., Armenta, R. A., Wagner, K. D., Roesch, S. C., Bluthenthal, R. N., Cuevas-Mota, J., & Garfein, R. S. (2015). Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: A latent class analysis. Substance Use & Misuse, 50(2), 205–214. doi:10.3109/10826084.2014.962661
   PubMed Web of Science ®Google Scholar
• Sara, G., Burgess, P., Harris, M., Malhi, G. S., Whiteford, H., & Hall, W. (2012). Stimulant use disorders: Characteristics and comorbidity in an Australian population sample. Australian & New Zealand Journal of Psychiatry, 46(12), 1173–1181. doi:10.1177/0004867412461057
   PubMed Web of Science ®Google Scholar
• Schottenfeld, R. S., Pakes, J., Ziedonis, D., & Kosten, T. R. (1993). Buprenorphine: Dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biological Psychiatry, 34(1), 66–74. doi:10.1016/0006-3223(93)90258-F
   PubMed Web of Science ®Google Scholar
• Shariatirad, S., Maarefvand, M., & Ekhtiari, H. (2013). Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. The International Journal on Drug Policy, 24(6), e115. doi:10.1016/j.drugpo.2013.05.003
   PubMedGoogle Scholar
• Torok, M., Darke, S., & Kaye, S. (2012). Attention deficit hyperactivity disorder and severity of substance use: the role of comorbid psychopathology. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 26(4), 974–979. doi:10.1037/a0027846
   PubMed Web of Science ®Google Scholar
• Van Meer, R. (2014). Stimulant substitution in methamphetamine dependence from the perspective of adult ADHD. Australian & New Zealand Journal of Psychiatry, 48(1), 95–96. doi:10.1177/0004867413492221
   PubMed Web of Science ®Google Scholar